Upper arm intermittent ischaemia reduces exercise-related increase of platelet reactivity in patients with

Irma Battipaglia1, Giancarla Scalone, Maria Milo

  • 1Istituto di Cardiologia, Università Cattolica del Sacro Cuore, Roma, Italy.

Insights

Remote ischaemia, a brief interruption of blood flow in the arm, was found to protect against exercise-related increases in platelet activation in patients with coronary artery disease (CAD). This finding suggests a potential protective mechanism against cardiovascular events.

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Vascular Biology

Background:

  • Coronary artery disease (CAD) involves myocardial ischaemia during exercise.
  • Platelet activation plays a crucial role in atherothrombosis.
  • Understanding factors that modulate exercise-induced platelet activation is vital for cardiovascular risk management.

Purpose of the Study:

  • To investigate the impact of remote ischaemia on exercise-induced myocardial ischaemia.
  • To assess the effect of remote ischaemia on platelet activation in patients with stable CAD.

Main Methods:

  • A crossover study design was employed with 20 patients with stable CAD.
  • Patients underwent two maximal exercise stress tests (ESTs): one standard (EST-1) and one following intermittent upper arm ischaemia (EST-2).
  • Platelet reactivity was measured using flow cytometry, assessing monocyte-platelet aggregates (MPAs) and CD41 expression.

Main Results:

  • Remote ischaemia did not significantly alter exercise-induced myocardial ischaemia.
  • While basal platelet reactivity was similar before both ESTs, ADP stimulation post-EST-2 resulted in a significantly lower increase in MPAs and CD41 expression compared to post-EST-1.
  • This indicates a protective effect of remote ischaemia against exercise-induced platelet activation.

Conclusions:

  • Remote ischaemia confers protection against exercise-related increases in platelet reactivity in patients with stable CAD.
  • This phenomenon, known as the 'ischaemic preconditioning' effect, may have implications for reducing thrombotic events in CAD patients.
  • Further research is warranted to explore the clinical utility of remote ischaemia in cardiovascular disease management.
Abstract

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...